Alignment Healthcare (ALHC) Scheduled to Post Earnings on Thursday

Alignment Healthcare (NASDAQ:ALHC) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, May 2nd. Analysts expect Alignment Healthcare to post earnings of ($0.24) per share for the quarter. Alignment Healthcare has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Individual that wish to register for the company’s earnings conference call can do so using this link.

Alignment Healthcare (NASDAQ:ALHC) last posted its earnings results on Tuesday, February 27th. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.22) by ($0.03). Alignment Healthcare had a negative return on equity of 75.64% and a negative net margin of 8.12%. The business had revenue of $465.39 million for the quarter, compared to analysts’ expectations of $444.56 million. During the same quarter in the previous year, the firm earned ($0.31) earnings per share. Alignment Healthcare’s quarterly revenue was up 28.6% compared to the same quarter last year. On average, analysts expect Alignment Healthcare to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Alignment Healthcare Price Performance

ALHC opened at $5.18 on Thursday. The stock has a 50-day moving average price of $5.28 and a 200-day moving average price of $6.62. Alignment Healthcare has a 12-month low of $4.46 and a 12-month high of $9.20. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 1.02. The stock has a market capitalization of $978.92 million, a P/E ratio of -6.56 and a beta of 1.30.

Insider Buying and Selling at Alignment Healthcare

In other news, insider Dawn Christine Maroney sold 15,861 shares of the stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $5.05, for a total value of $80,098.05. Following the completion of the transaction, the insider now owns 1,999,500 shares of the company’s stock, valued at approximately $10,097,475. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Dawn Christine Maroney sold 15,861 shares of the stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $5.05, for a total value of $80,098.05. Following the completion of the transaction, the insider now owns 1,999,500 shares of the company’s stock, valued at approximately $10,097,475. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Robert Thomas Freeman sold 28,522 shares of the stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $5.05, for a total value of $144,036.10. Following the completion of the transaction, the chief financial officer now directly owns 869,706 shares of the company’s stock, valued at approximately $4,392,015.30. The disclosure for this sale can be found here. Insiders sold 90,213 shares of company stock valued at $460,587 in the last 90 days. Insiders own 6.30% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently issued reports on ALHC. Piper Sandler reiterated a “neutral” rating and issued a $6.00 price objective (down from $12.00) on shares of Alignment Healthcare in a report on Wednesday, March 6th. Stephens upped their price objective on Alignment Healthcare from $10.00 to $10.50 and gave the stock an “equal weight” rating in a report on Tuesday, January 9th. William Blair reiterated an “outperform” rating on shares of Alignment Healthcare in a report on Wednesday, March 6th. Raymond James boosted their target price on Alignment Healthcare from $10.00 to $12.00 and gave the company a “strong-buy” rating in a research note on Tuesday, January 9th. Finally, Stifel Nicolaus lowered their target price on Alignment Healthcare from $11.00 to $9.00 and set a “buy” rating for the company in a research note on Tuesday. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $9.18.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.